A Passion for Our Work
SomaLogic is a community of people with diverse expertise but a singular purpose — to provide the insights that help people everywhere manage their personal health and wellness.
Our team of world-class scientists, directors and administrators work together in a shared culture of commitment to making a difference in the world.
Senior Management
Roy Smythe
Chief Executive Officer
Melody Harris
President
Matthew Norkunas
Chief Financial Officer
Stephen A. Williams
Chief Medical Officer
Nebojsa Janjic
Chief Science Officer
Alan Williams
Chief Development and Operations Officer
Fintan Steele
Chief Corporate Communications & Culture Officer
Mark Messenbaugh
Senior Vice President, Global Markets
Board of Directors
Larry Gold
Chairman and Founder of SomaLogic
Charles M. Lillis
Founder and Managing Partner of LoneTree Capital
Former Chairman and CEO of Media One Group
Jessica Tuchman Mathews
Former President of the Carnegie Endowment for International Peace
Terry L. Randall
Vice Chairman of the Board of Mellott Company
President-CEO of Heritage Capital, LLC.
Alister (Al) W. Reynolds
Former CEO of SomaLogic
Former Senior Vice President of Quest Diagnostics
Takayuki Shiratsuchi
Operating Officer & General Manager of Basic Research at Otsuka Pharmaceutical Co., Ltd.
Roy Smythe
Chief Executive Officer
Jun Wang
Founder and CEO of iCarbonX
Advisors
Sir Marc Feldmann
Emeritus Professor, University of Oxford, UK
Peter Ganz
Professor, University of California, San Francisco School of Medicine
David Lawrence
Former Chairman & CEO, Kaiser Permanente
Sir Simon Lovestone
Professor, University of Oxford, UK
Craig Mundie
President, Mundie & Associates; Former Chief Research & Strategy Officer, Microsoft
Russell T. Ray
Member of the Board of Directors, Merrimack Pharmaceuticals; Former Vice Chairman & Managing Director of the Stifel, Inc. Healthcare Investment Banking Group; Former General Partner at HLM Venture Partners; Global Co-Head of Healthcare Investment Banking at Credit Suisse First Boston
Elio Riboli
Director, School of Public Health, Imperial College, London
John Stuelpnagel
Executive Chairman, Ariosa Diagnostics; Founder and former CEO & COO, Illumina